You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PBSC's

Showing 1 - 25 of 618
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia Trial in United States (drug, procedure, other, radiation)

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +10 more
  • Jacksonville, Florida
  • +5 more
Aug 14, 2023

AIDS-related Lymphoma, HIV Trial in Hamburg (PBSC-M87o, Gene (M87o)-modified, CD34+ peripheral blood progenitor cells (PBSC))

Terminated
  • AIDS-related Lymphoma
  • HIV Infections
  • PBSC-M87o, Gene (M87o)-modified, CD34+ peripheral blood progenitor cells (PBSC)
  • Hamburg, Germany
    University Medical Center Hamburg-Eppendorf
Sep 4, 2022

Fanconi Anemia, Severe Aplastic Anemia, MDS Trial in Minneapolis (Total Body Irradiation (TBI) (Plan 1), Cyclophosphamide (CY)

Recruiting
  • Fanconi Anemia
  • +2 more
  • Total Body Irradiation (TBI) (Plan 1)
  • +8 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Nov 2, 2022

Acute Leukemia, MDS, Myeloproliferative Tumor Trial in Minneapolis (VIC- 1911)

Recruiting
  • Acute Leukemia
  • +3 more
  • VIC- 1911
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Apr 12, 2022

Hematologic Malignancy, Acute Leukemia, Remission Trial (Fludarabine, Busulfan, Melphalan)

Not yet recruiting
  • Hematologic Malignancy
  • +21 more
  • (no location specified)
Feb 9, 2023

Hematological Malignancies, Hematopoietic Stem Cell Transplantation Trial in Guangzhou (PBSCs, Cord, BMSCs)

Recruiting
  • Hematological Malignancies
  • Hematopoietic Stem Cell Transplantation
  • PBSCs
  • +2 more
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Mar 13, 2022

Leukemia Trial in Shanghai (CLAM+PBSC)

Suspended
  • Leukemia
  • Shanghai, China
    Rui Jin Hospital, Department of Hematology
Nov 23, 2021

Sickle Cell Anemia Trial run by the NHLBI (PBSC Transplant, Alemtuzumab, Sirolimus)

Active, not recruiting
Has Results
  • Sickle Cell Anemia
  • PBSC Transplant
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 13, 2022

Non-Hodgkin Lymphoma, Hodgkin Lymphoma Trial in Minneapolis (drug, procedure, biological, radiation)

Recruiting
  • Non-Hodgkin Lymphoma
  • Hodgkin Lymphoma
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Jan 25, 2023

Hemophilia A Trial in Milwaukee (Auto CD34+PBSC, transduced with a lentiviral vector encoding the B domain deleted from of human

Recruiting
  • Hemophilia A
  • Auto CD34+PBSC, transduced with a lentiviral vector encoding the B domain deleted from of human coagulation factor VIII
  • Milwaukee, Wisconsin
    Froedtert Hospital and the Medical College of Wisconsin
Dec 21, 2022

MDS, Graft Vs Host Disease, Graft-versus-host-disease Trial in Miami (Busulfan, Melphalan, Fludarabine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Miami, Florida
    Miami Cancer Institute
Jan 10, 2023

Proliferative Potential of H-PBSC Based on Demographics and

Recruiting
  • Healthy
  • Cellular analysis
  • Gulf Breeze, Florida
    Andrews Research & Education Foundation
Oct 6, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +7 more
  • Duarte, California
  • +26 more
Aug 11, 2022

Neuroblastoma Trial in Minneapolis (drug, biological, radiation)

Recruiting
  • Neuroblastoma
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Apr 11, 2022

Refractory Non Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma Trial in Sacramento (biological, radiation, procedure, drug)

Active, not recruiting
  • Refractory Non Hodgkin Lymphoma
  • Relapsed Non Hodgkin Lymphoma
  • rituximab
  • +7 more
  • Sacramento, California
    University of California Davis
Nov 28, 2022

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Rochester (Hyperbaric oxygen)

Recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Hyperbaric oxygen
  • Rochester, New York
    Wilmot Cancer Institute, University of Rochester
May 16, 2022

Leukemia, Bone Marrow Failure Syndrome, Immunodeficiencies Trial in Philadelphia (Apha/beta T and CD19+ cell depletion using

Available
  • Leukemia
  • +2 more
  • Apha/beta T and CD19+ cell depletion using CliniMACS device
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Nov 2, 2021

Leukemia, Inborn Errors of Metabolism, Bone Marrow Failure Syndromes Trial in Philadelphia (Transplant of stem cells with

Recruiting
  • Leukemia
  • +4 more
  • Transplant of stem cells with CD3+/CD19+ depletion (CliniMACs)
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Nov 2, 2021

Crohn's Disease Trial in Pittsburgh (autologous CD34-selected peripheral blood stem cells transplant, Alemtuzumab, ATG)

Recruiting
  • Crohn's Disease
  • autologous CD34-selected peripheral blood stem cells transplant
  • +8 more
  • Pittsburgh, Pennsylvania
  • +1 more
Feb 9, 2022

Systemic Sclerosis, Diffuse Sclerosis Systemic, Interstitial Lung Disease Trial in Pittsburgh (Cyclophosphamide, Mesna,

Recruiting
  • Systemic Sclerosis
  • +3 more
  • Pittsburgh, Pennsylvania
  • +2 more
Dec 17, 2021

AML, ALL, MDS Trial in Germany (Peripheral blood stem cells)

Recruiting
  • AML
  • +2 more
  • Peripheral blood stem cells
  • Bonn, Germany
  • +8 more
Aug 25, 2021

Related Donors Donating PBSC to a Family Member, Healthy Donors, Acute Myelogenous Leukemia Trial in United States (MGTA-145,

Terminated
  • Related Donors Donating PBSC to a Family Member
  • +4 more
  • MGTA-145
  • Plerixafor
  • Duarte, California
  • +7 more
Apr 13, 2022

Aml, AML, Adult Trial (Nivolumab, Azacitidine)

Withdrawn
  • Aml
  • AML, Adult
  • (no location specified)
Oct 9, 2020

Autologous Hematopoietic Stem Cell Transplant Recipient, Loss of Chromosome 17p, Plasma Cell Leukemia Trial in Duarte (drug,

Active, not recruiting
  • Autologous Hematopoietic Stem Cell Transplant Recipient
  • +4 more
  • Duarte, California
    City of Hope
Mar 17, 2022

Multiple Myeloma Trial in Little Rock (myPRS, Induction 1 - MEL-10+CFZ-TD-PACE, First Transplant - MEL-80+CFZ-TD-PACE + PBSC

Terminated
Has Results
  • Multiple Myeloma
  • myPRS
  • +6 more
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
May 28, 2021